Core Highlights: - No revenue as the company is pre-revenue stage
- Cash position strengthened significantly to $288.5 million after the SPAC merger in May 2024
- Operating expenses of $37.4 million for 9 months, mainly R&D and G&A costs
Revenue Breakdown: - No revenue yet as the Aurora powerhouse product line is still being developed
- Plans to commercialize liquid metal fast reactor technology, with first 15-50 MWe Aurora plant targeted for 2027 deployment
Management Outlook: - Expects cash runway to fund operations for at least 12 months based on current cash
- Key milestones include securing site permit, fuel award for Idaho plant
- Focused on developing and deploying first commercial advanced fission power plant
Operating Data: - Operating expenses of $37.4M for 9 months, $24.9M cash used in operations
- Raised $10.2M from SAFEs, $25M right of first refusal liability recorded
- Under current loss rate, cash can support operations for over 7 quarters
Operational Risks: - Pursuing emerging market with no operating commercial project yet
- Faces regulatory uncertainties, needs financing to construct plants
- Risks from competition, market conditions, proposed Atomic Alchemy acquisition
Original Filing
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。